Literature DB >> 24581791

Lean versus obese diabetes mellitus patients in the United States minority population.

Nathaniel J Coleman1, Jadwiga Miernik1, Louis Philipson2, Leon Fogelfeld3.   

Abstract

OBJECTIVE: To identify special characteristics in large group of lean diabetes minority patients in comparison to obese type 2 diabetes.
METHODS: 1784 Lean (BMI <25) diabetes patients were identified and compared with 8630 obese (BMI ≥30) patients. Patients with Type 1 Diabetes (N=523) were excluded. Patient data, including demographics, psychosocial factors, insulin use, and complications was analyzed.
RESULTS: In lean compared to obese, there was male predominance (62% vs 48%, p<0.001), higher prevalence of insulin use (49% vs 44%, p=0.001), lower TG/HDL (2.28 vs 3.4, p<0.001), and higher prevalence of alcoholism (5.7% vs 2.4%, p<0.001) and pancreatitis (3.6% vs 0.9%, p<0.001). In both groups, African Americans and Latinos were the prevalent ethnicities (38%, 34% vs. 53%,31%). When comparing patients within the lean group who were on insulin (49%) to those on oral medications, there were more males (65% vs. 59%, p<0.001), earlier age of onset (40±14 vs. 47±12, p<0.001), lower BMI (22.1±2 vs. 22.6±1.7, p<0.001) and lower TG/HDL (2.18 vs. 2.42, p=0.021).
CONCLUSIONS: A subset of diabetes patients in the United States minority population are lean and may have rapid beta cell failure. The etiology is not clear and acquired factors, genetics, and autoimmunity may be contributory.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes in minorities; Lean diabetes; Pancreatitis

Mesh:

Substances:

Year:  2013        PMID: 24581791     DOI: 10.1016/j.jdiacomp.2013.11.010

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  29 in total

1.  Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis.

Authors:  Tito Borner; Jayme L Workinger; Ian C Tinsley; Samantha M Fortin; Lauren M Stein; Oleg G Chepurny; George G Holz; Aleksandra J Wierzba; Dorota Gryko; Ebba Nexø; Evan D Shaulson; Ankur Bamezai; Valentina A Rodriguez Da Silva; Bart C De Jonghe; Matthew R Hayes; Robert P Doyle
Journal:  Cell Rep       Date:  2020-06-16       Impact factor: 9.423

2.  The villain with a thousand faces.

Authors:  Ashok Balasubramanyam
Journal:  J Diabetes Complications       Date:  2014-02-18       Impact factor: 2.852

3.  Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Takuya Fukuda; Akihiro Ohbora; Takao Kojima; Michiaki Fukui
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

4.  A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodents.

Authors:  Elizabeth G Mietlicki-Baase; Claudia G Liberini; Jayme L Workinger; Ron L Bonaccorso; Tito Borner; David J Reiner; Kieran Koch-Laskowski; Lauren E McGrath; Rinzin Lhamo; Lauren M Stein; Bart C De Jonghe; George G Holz; Christian L Roth; Robert P Doyle; Matthew R Hayes
Journal:  Diabetes Obes Metab       Date:  2018-02-20       Impact factor: 6.577

5.  Novel lean type 2 diabetic rat model using gestational low-protein programming.

Authors:  Chellakkan S Blesson; Amy K Schutt; Meena P Balakrishnan; Robia G Pautler; Steen E Pedersen; Poonam Sarkar; Daniel Gonzales; Gang Zhu; Juan C Marini; Shaji K Chacko; Uma Yallampalli; Chandra Yallampalli
Journal:  Am J Obstet Gynecol       Date:  2016-02-10       Impact factor: 8.661

6.  Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients.

Authors:  Hannah Mathew; Olivia M Farr; Christos S Mantzoros
Journal:  Metabolism       Date:  2015-10-23       Impact factor: 8.694

Review 7.  Lean diabetes mellitus: An emerging entity in the era of obesity.

Authors:  Amrutha Mary George; Amith George Jacob; Leon Fogelfeld
Journal:  World J Diabetes       Date:  2015-05-15

8.  Recruitment and Baseline Characteristics of Participants in the Lifestyle Improvement Through Food and Exercise (LIFE) Study.

Authors:  Elizabeth Lynch; Laurin J Mack; Kelly Karavolos; Elizabeth Avery; Rebecca Liebman; Kathryn S Keim; Crystal M Glover; Leon Fogelfeld
Journal:  J Health Care Poor Underserved       Date:  2017

Review 9.  Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight.

Authors:  Mohammed Eslam; Hashem B El-Serag; Sven Francque; Shiv K Sarin; Lai Wei; Elisabetta Bugianesi; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-16       Impact factor: 73.082

10.  Sociodemographic and metabolic risk characteristics associated with metabolic weight categories in the Women's Health Initiative.

Authors:  Amber R Cordola Hsu; Susan L Ames; Bin Xie; Darleen V Peterson; Lorena Garcia; Scott B Going; Nathan D Wong; Hoda Anton-Culver
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.